Please Provide Us with a Reasonable Definition for Curative R0 Resection in Barrett's Esophagus Neoplasia; Which One Should We Choose?
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Manner H, Pech O, Heldmann Y, May A, Pauthner M, Lorenz D
. The frequency of lymph node metastasis in early-stage adenocarcinoma of the esophagus with incipient submucosal invasion (pT1b sm1) depending on histological risk patterns. Surg Endosc. 2014; 29(7):1888-96.
DOI: 10.1007/s00464-014-3881-3.
View
2.
Montgomery E, Bronner M, Goldblum J, Greenson J, Haber M, Hart J
. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol. 2001; 32(4):368-78.
DOI: 10.1053/hupa.2001.23510.
View
3.
Manner H, May A, Pech O, Gossner L, Rabenstein T, Gunter E
. Early Barrett's carcinoma with "low-risk" submucosal invasion: long-term results of endoscopic resection with a curative intent. Am J Gastroenterol. 2008; 103(10):2589-97.
DOI: 10.1111/j.1572-0241.2008.02083.x.
View
4.
Shaheen N, Sharma P, Overholt B, Wolfsen H, Sampliner R, Wang K
. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med. 2009; 360(22):2277-88.
DOI: 10.1056/NEJMoa0808145.
View
5.
Fitzgerald R, di Pietro M, Ragunath K, Ang Y, Kang J, Watson P
. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut. 2013; 63(1):7-42.
DOI: 10.1136/gutjnl-2013-305372.
View